1. NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
   Shan Qin et al, 2017, Bioscience Reports CrossRef
2. Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction
   Hajar Alemohammad et al, 2020, Life Sciences CrossRef
3. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
   Jose Marin et al, 2019, Cancers CrossRef
4. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer
   Arijita Basu et al, 2021, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
5. Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint
   Yaser E. Alqurashi et al, 2023, Environmental Research CrossRef
6. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
   Aparna Jayachandran et al, 2016, Journal of Hematology & Oncology CrossRef
7. P18 peptide, a functional fragment of pigment epithelial-derived factor, inhibits angiogenesis in hepatocellular carcinoma via modulating VEGF/VEGFR2 signalling pathway
   Xin Wang et al, 2017, Oncology Reports CrossRef
8. Deregulation of Stemness-Related Genes in Endometriotic Mesenchymal Stem Cells: Further Evidence for Self-Renewal/Differentiation Imbalance
   Parisa Mashayekhi et al, 2020, Iranian Biomedical Journal CrossRef
9. Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model
   Bigang Liu et al, 2017, Oncotarget CrossRef